| 臺大學術典藏 |
2020-09-30T08:49:16Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Wang J.-H.; Chang K.-C.; Lin T.-H.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Ho S.-K.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J.; Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I. |
| 臺大學術典藏 |
2020-06-01T06:31:24Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Jong C.-B.;Hung-Yuan Li;Pan S.-L.;Hsieh M.-Y.;Su F.-Y.;Chen K.-C.;Yin W.-H.;Chan S.-H.;Wu Y.-W.;Wang K.-Y.;Chang K.-C.;Hwang J.-J.;Wu C.-C.; Jong C.-B.; HUNG-YUAN LI; Pan S.-L.; Hsieh M.-Y.; Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; Wu Y.-W.; Wang K.-Y.; Chang K.-C.; Hwang J.-J.; Wu C.-C. |
| 臺大學術典藏 |
2020-04-07T07:00:52Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; Wu Y.-W.; Wang K.-Y.; Chang K.-C.; Hwang J.-J.; Wu C.-C.; SHIN-LIANG PAN; Hsieh M.-Y.; Li H.-Y.; Jong C.-B.; Jong C.-B.;Li H.-Y.;Shin-Liang Pan;Hsieh M.-Y.;Su F.-Y.;Chen K.-C.;Yin W.-H.;Chan S.-H.;Wu Y.-W.;Wang K.-Y.;Chang K.-C.;Hwang J.-J.;Wu C.-C. |
| 臺大學術典藏 |
2020-03-04T09:03:16Z |
The Effect of Surgical Weight Reduction on Left Ventricular Structure and Function in Severe Obesity
|
Hsuan C.-F.;Huang C.-K.;Lin J.-W.;Lin L.-C.;Lee T.-L.;Tai C.-M.;Yin W.-H.;Tseng W.-K.;Hsu K.-L.;Chau-Chung Wu; Hsuan C.-F.; Huang C.-K.; Lin J.-W.; Lin L.-C.; Lee T.-L.; Tai C.-M.; Yin W.-H.; Tseng W.-K.; Hsu K.-L.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:13Z |
2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the diagnosis and treatment of heart failure
|
Wang C.-C.; Chen J.-H.; Yu W.-C.; Cheng J.-J.; Yin W.-H.; CHAU-CHUNG WU; Li A.-H.; Lin W.-S.; Chen P.-S.; Ueng K.-C.; Huang J.-L.; Tsai F.-C.; Wang C.-H.; Fu T.-C.; Liu M.-H.; Chen P.-R.; Pai H.-Y.; Cherng W.-J. |
| 臺大學術典藏 |
2020-03-04T09:03:12Z |
Registry of lipid control and the use of lipid-lowering drugs for secondary prevention of cardiovascular events in patients with established atherosclerotic disease in Taiwan: Rationality and methods
|
Yin W.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:11Z |
Gender difference in statin intervention on blood lipid control among patients with coronary heart disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:10Z |
Gender disparities in optimal lipid control among patients with coronary artery disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:10Z |
Increased rosuvastatin dose versus concomitant fenofibrate and rosuvastatin therapy to achieve lipid goal in patients with diabetes or atherosclerosis with metabolic syndrome
|
Yin W.-H.; Chen J.-W.; Lee Y.-T.; CHAU-CHUNG WU; Tseng W.-K.; Chen Y.-P.;Chang K.-C.;Tseng W.-K.;Yin W.-H.;Chen J.-W.;Lee Y.-T.;Chau-Chung Wu; Chen Y.-P.; Chang K.-C. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Combination with low-dose dextromethorphan improves the effect of amlodipine monotherapy in clinical hypertension a first-in-human, concept-proven, prospective, dose-escalation, multicenter study
|
Yin W.-H.; Chen P.; Yeh H.-I.; Wang K.-Y.; Hung Y.-J.; Tseng W.-K.; Wen M.-S.; Wu T.-C.; CHAU-CHUNG WU; Cheng S.-M.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:04Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
Lin F.-J.;Tseng W.-K.;Yin W.-H.;Yeh H.-I.;Chen J.-W.;Chau-Chung Wu; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-03T02:28:40Z |
Magnolol: A multifunctional compound isolated from the Chinese medicinal plant Magnolia officinalis
|
Chen Y.-H. ;Huang P.-H. ;Lin F.-Y. ;Chen W.-C. ;Yuh-Lien Chen ;Yin W.-H. ;Man K.-M. ;Liu P.-L.; Chen Y.-H.; Huang P.-H.; Lin F.-Y.; Chen W.-C.; YUH-LIEN CHEN; Yin W.-H.; Man K.-M.; Liu P.-L. |
| 臺大學術典藏 |
2020-03-03T02:28:38Z |
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization
|
Liu J.-T.; YUH-LIEN CHEN; Chen W.-C.; Chen H.-Y.; Lin Y.-W.; Wang S.-H.; Man K.-M.; Wan H.-M.; Yin W.-H.; Liu P.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2020-03-02T07:45:18Z |
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization
|
Liu J.-T.;Chen Y.-L.;Chen W.-C.;Chen H.-Y.;Lin Y.-W.;Shu-Huei Wang;Man K.-M.;Wan H.-M.;Yin W.-H.;Liu P.-L.;Chen Y.-H.; Liu J.-T.; Chen Y.-L.; Chen W.-C.; Chen H.-Y.; Lin Y.-W.; SHU-HUEI WANG; Man K.-M.; Wan H.-M.; Yin W.-H.; Liu P.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2020-02-27T07:42:38Z |
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
|
Chiang C.-E.; Wu T.-J.; Ueng K.-C.; Chao T.-F.; Chang K.-C.; Wang C.-C.; Lin Y.-J.; Yin W.-H.; Kuo J.-Y.; Lin W.-S.; Tsai C.-T.; Liu Y.-B.; Lee K.-T.; Lin L.-J.; Lin L.-Y.; Wang K.-L.; Chen Y.-J.; Chen M.-C.; Cheng C.-C.; Wen M.-S.; WEN-JONE CHEN; Chen J.-H.; Lai W.-T.; Chiou C.-W.; Lin J.-L.; Yeh S.-J.; Chen S.-A.; Chen S.-A.;Yeh S.-J.;Lin J.-L.;Chiou C.-W.;Lai W.-T.;Chen J.-H.;WEN-JONE CHEN;Wen M.-S.;Cheng C.-C.;Chen M.-C.;Chen Y.-J.;Wang K.-L.;Lin L.-Y.;Lin L.-J.;Lee K.-T.;Liu Y.-B.;Tsai C.-T.;Lin W.-S.;Kuo J.-Y.;Yin W.-H.;Lin Y.-J.;Wang C.-C.;Chang K.-C.;Chao T.-F.;Ueng K.-C.;Wu T.-J.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-25T09:38:31Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Fang-Ju Lin;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.; Tsai, H.-S.; Tseng, W.-K.; Yin, W.-H.; FANG-JU LIN; Hsuan, C.-F.; Wu, Y.-W.; Huang, L.-C.; Lin, T.-H.; Chang, K.-C.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:10:00Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
FANG-JU LIN; Tseng, W.-K.; Yin, W.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020 |
Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia
|
HSIEN-LI KAO; Seth A.; Park D.-W.; Yin W.-H.; Chen M.; Hayashida K.; Tay E.L.; Lee M.; Firman D.; Hon J.; Rosli M.A.; Lin M.-S.; Ho K.-W.; Buddhari W.; Chandavimol M.; Posas F.-E.; Nguyen Q.N.; Kong W. |
| 國立成功大學 |
2020 |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang, Chiang C.-E.;Ueng, K.-C.;Chao, T.-H.;Lin, T.-H.;Wu, Y.-J.;Wang, K.-L.;Sung, Sung S.-H.;Yeh, H.-I.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Shyu, K.-G.;Huang, J.-L.;Tsai, C.-D.;Hung, Hung H.-F.;Liu, M.-E.;Chao, T.-F.;Cheng, S.-M.;Cheng, H.-M.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Chen, W.-J.;Lai, W.-T.;Lin, S.-J.;Yeh, S.-J.;Hwang, J.-J. |
| 國立成功大學 |
2020 |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li, Y.-H.;Tseng, W.-K.;Yin, W.-H.;Lin, F.-J.;Wu, Y.-W.;Hsieh, I.-C.;Lin, T.-H.;Sheu, W.H.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.;Investigators, Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry |
| 臺大學術典藏 |
2019-05-24T03:24:35Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Chang, K.-C.;Wang, K.-Y.;Chan, S.-H.;Yin, W.-H.;Chen, K.-C.;Su, F.-Y.;Hsieh, M.-Y.;CHIH-CHENG WU;Li, H.-Y.;Jong, C.-B.;HWANG, JUEY-JEN;WU, YEN-WEN;PAN, SHIN-LIANG; Jong, C.-B.; Li, H.-Y.; PAN, SHIN-LIANG; Hsieh, M.-Y.; Su, F.-Y.; Chen, K.-C.; Yin, W.-H.; Chan, S.-H.; WU, YEN-WEN; Wang, K.-Y.; Chang, K.-C.; HWANG, JUEY-JEN; CHIH-CHENG WU |
| 臺大學術典藏 |
2019 |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Cheng Chang K.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Leu H.-B.; Yin W.-H.; Chen J.-W.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2019 |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Wu C.-C.; Chen J.-W.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Yin W.-H.; Tseng W.-K.; Tsai H.-S. |
| 臺大學術典藏 |
2019 |
2019 focused update of the guidelines of the Taiwan society of cardiology for the diagnosis and treatment of heart failure
|
Hwang J.-J.; Lin J.-L.; CHIA-TI TSAI; Wu Y.-W.; Yin W.-H.; Cherng W.-J.; Wang C.-C.; Wu C.-K.; Tsai M.-L.; Lee C.-M.; Huang W.-C.; Chou H.-H.; Huang J.-L.; Chi N.-H.; Yen H.-W.; Tzeng B.-H.; Chang W.-T.; Chang H.-Y.; Wang C.-H.; Lu Y.-Y.; Tsai J.-P.; Su C.-H. |
| 國立成功大學 |
2019 |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Lin, F.-J.;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C. |
| 國立成功大學 |
2019 |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Jong, C.-B.;Li, H.-Y.;Pan, S.-L.;Hsieh, M.-Y.;Su, F.-Y.;Chen, K.-C.;Yin, W.-H.;Chan, S.-H.;Wu, Y.-W.;Wang, K.-Y.;Chang, K.-C.;Hwang, J.-J.;Wu, C.-C. |
| 臺大學術典藏 |
2018-09-10T18:03:15Z |
One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry
|
Chang, H.-Y. and Wang, C.-C. and Wu, Y.-W. and Chu, P.-H. and Wu, C.-C. and Hsu, C.-H. and Wen, M.-S. and Voon, W.-C. and Lin, W.-S. and Huang, J.-L. and Chen, S.-M. and Yang, N.-I. and Chang, H.-C. and Chang, K.-C. and Sung, S.-H. and Shyu, K.-G. and Lin, J.-L. and Mar, G.-Y. and Chan, K.-C. and Kuo, J.-Y. and Wang, J.-H. and Chen, Z.-C. and Tseng, W.-K. and Cherng, W.-J. and Yin, W.-H.; Chang, H.-Y.; Wang, C.-C.; Chu, P.-H.; Hsu, C.-H; Wen, M.-S.; Voon, W.-C.; Lin, W.-S.; Huang, J.-L.; Chen, S.-M.; Yang, N.-I.; Chang, H.-C.; Chang, K.-C.; Sung, S.-H.; Shyu, K.-G.; Lin, J.-L.; Mar, G.-Y.; Chan, K.-C. ; Kuo, J.-Y.; Wang, J.-H.; Chen, Z.-C.; Tseng, W.-K.; Cherng, W.-J.; Yin, W.-H.; YEN-WEN WU; CHIH-CHENG WU |
| 國立成功大學 |
2018 |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho, L.-T.;Lin, F.-J.;Tseng, W.-K.;Yin, W.-H.;Wu, Y.-W.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.;Investigators, the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry |
| 國立成功大學 |
2018 |
In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry
|
Chen, K.-C.;Yin, W.-H.;Wu, C.-C.;Chan, S.-H.;Wu, Y.-W.;Wang, K.Y.;Chang, K.-C.;Hwang, J.-J.;Voon, W.-C.;Hsieh, I.-C.;Chong, J.-T.;Lin, W.-S.;Hsu, C.-N.;Ueng, K.-C.;Hsia, C.-P.;Liu, J.-C.;Yeh, J.-S.;Mar, G.-Y.;Shih, J.-Y.;Kuo, J.-Y.;Tsao, H.-M.;Tseng, W.-K.;Yang, C.-H.;Chang, Chang C.-C.;Chiang, Chiang C.-E.;Lei, M.-H.;Lin, J.-F.;Shyu, K.-G. |
| 國立成功大學 |
2018 |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang, Chiang C.-E.;Lin, S.-Y.;Lin, T.-H.;Wang, T.-D.;Yeh, H.-I.;Chen, J.-F.;Tsai, C.-T.;Hung, Y.-J.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Wang, K.-L.;Chao, T.-H.;Shyu, K.-G.;Yang, W.-S.;Ueng, K.-C.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Cheng, H.-M.;Shin, Shin S.-J.;Huang, C.-N.;Chuang, L.-M.;Lin, S.-J.;Yeh, S.-J.;Sheu, W.H.-H.;Lin, J.-L. |
| 國立成功大學 |
2018 |
Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001–2013
|
Liang, F.-W.;Lee, J.-C.;Lu, T.-H.;Yin, W.-H. |
| 國立成功大學 |
2018 |
When high-volume PCI operators in high-volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes?
|
Lu, T.-H.;Li, S.-T.;Liang, F.-W.;Lee, J.-C.;Yin, W.-H. |
